News
Broad access to the fruits of NIH’s investments—whether in the form of data, results, or products—drives innovation. To advance this aim, NIH is launching a new policy to improve access to medical products developed from NIH-owned inventions. This policy emphasizes the importance of proactive
Register to attend the National Cancer Institute Technology Transfer Center's first NIH technology webinar of the year on May 22nd, 2024 at 11AM ET. Attendees will learn about a potential, novel treatment for Retinitis Pigmentosa (RP). Over 100,000 people in the U.S. and 1.5 million people worldwide
A mouse cell line engineered to produce camelid nanobodies for use against infectious diseases or for basic applications is available for licensing. Nanobodies: have equivalent binding specificity to antigens as antibodies but are more heat- and detergent-stable. can target epitopes that are not
Inventors at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) have created a wearable, wireless device and protocol for continuously monitoring pregnancy health. The device can monitor placental oxygenation levels, multiple physiological signals and